Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
PROVECTUS BIOPHARMACEUTICALS, INC. | CTO | Series D-1 Convertible Preferred Stock | 1.39M | Jun 20, 2021 | Direct | ||
PROVECTUS BIOPHARMACEUTICALS, INC. | CTO | 8% Secured Convertible Promissory Notes due 2021 | 0 | Jun 20, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | Jun 17, 2021 | 3 | $0 | 4 | Jun 22, 2021 | CTO |